L-DOPA DECARBOXYLATION IN CHRONICALLY TREATED PATIENTS

被引:21
作者
WARD, CD
TROMBLEY, IK
CALNE, DB
KOPIN, IJ
机构
[1] NIMH,CLIN SCI LAB,BETHESDA,MD 20205
[2] NINCDS,EXPTL THERAPEUT BRANCH,BETHESDA,MD 20205
关键词
D O I
10.1212/WNL.34.2.198
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
引用
收藏
页码:198 / 201
页数:4
相关论文
共 20 条
[1]  
ANDERSSON I, 1975, ACTA MED SCAND, V198, P415
[2]   DECARBOXYLATION OF ORALLY ADMINISTERED L-DOPA IN HUMAN DIGESTIVE TRACT [J].
BERGMARK, J ;
CARLSSON, A ;
SVANBORG, A ;
GRANERUS, AK ;
MAGNUSSON, T ;
JAGENBURG, R .
NAUNYN-SCHMIEDEBERGS ARCHIV FUR PHARMAKOLOGIE, 1972, 272 (04) :437-+
[3]  
BORRIVOLTATTORN.C, 1977, FEBS LETT, V75, P227
[4]   CAPILLARY BARRIER FOR DOPA IN BRAIN AND DIFFERENT ORGANS [J].
CONSTANT.J ;
DELATORR.JC ;
TISSOT, R ;
GEISSBUH.F .
PSYCHOPHARMACOLOGIA, 1969, 15 (02) :75-&
[5]   DECREASE IN LIVER AROMATIC L-AMINO-ACID DECARBOXYLASE PRODUCED BY CHRONIC ADMINISTRATION OF L-DOPA [J].
DAIRMAN, W ;
CHRISTENSON, JG ;
UDENFRIEND, S .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1971, 68 (09) :2117-+
[6]  
DEGRAZIA JA, 1972, P SEMINAR USE STABLE, P71
[7]  
DOLLER HJ, 1978, DRUG METAB DISPOS, V6, P164
[8]  
DUVOISIN RC, 1973, ADV NEUROL, V2, P574
[9]   ON-OFF PHENOMENON WITH LEVODOPA THERAPY IN PARKINSONISM - CLINICAL AND PHARMACOLOGIC CORRELATIONS AND EFFECT OF INTRAMUSCULAR PYRIDOXINE [J].
FAHN, S .
NEUROLOGY, 1974, 24 (05) :431-441